Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)

PHASE2/PHASE3RecruitingINTERVENTIONAL

Enrollment

117

Participants

Timeline

Start Date

April 8, 2017

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2027

Conditions

Primary Biliary Cholangitis

Interventions

DRUG

Fenofibrate

Fenofibrate (200 mg/day)

DRUG

UDCA

Ursodeoxycholic acid (13-15 mg/kg/day)

Trial Locations (1)

RECRUITING

Xijing Hospital, Xi'an

All Listed Sponsors

lead

Xijing Hospital of Digestive Diseases

OTHER